| Today's Open | $14.42 |
|---|---|
| Previous Close | $14.50 |
| Daily Range | $14.33 - $14.90 |
| 52-Week Range | $9.86 - $31.21 |
| Market Cap | $1.5B |
| P/E Ratio | -8.29 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 889,317 |
| Average Daily Volume | 2,716,425 |
| Current FY EPS | -$1.91 |
Sector
Healthcare
Industry
Drugs
VIVUS, Inc. (VVUS) Description
A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website: http://www.vivus.com/
News & Commentary
3 Pipeline Obesity Treatments You Should Watch
In the past year, two approved obesity drugs put the massive obesity market within reach of investors. Here are three treatments under development that could have even bigger consequences.The Surprising Link Between ADHD and Obesity
This disorder in childhood could put your adult health at risk.VVUS's Top Competitors
(3.66%)
(-0.58%)
(0.33%)
(0.14%)